Back to mobile site

More on FBLG

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.0 Score)

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

FibroBiologics (NQ:FBLG)
Delayed: 0.93 -0.03 (3.13%)
Prev. Close $0.96  
Open$0.96 
52 Wk High$ 
52 Wk Low$ 
Day High$1.04 
Day Low$0.93 
P/E N/A  
EPS$ 
Volume257,551 

Friends, Peers and Foes (?): ACCS, AREB, ASNS, BKYI, CJMB (more...)

Jun 3, 2026 07:00 AM FibroBiologics begins phase 1/2 trial for diabetic foot ulcer therapy
Jun 3, 2026 07:00 AM FibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabetic Foot Ulcers
May 22, 2026 08:30 AM FibroBiologics presents psoriasis data at dermatology meeting
May 22, 2026 08:30 AM FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting
May 18, 2026 08:30 AM FibroBiologics files patent for oral fibroblast drug delivery
May 18, 2026 08:30 AM FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics
May 11, 2026 08:30 AM FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus
May 6, 2026 07:03 AM Form 8-K FibroBiologics, Inc. For: May 05
May 6, 2026 06:02 AM Form 424B5 FibroBiologics, Inc.
May 5, 2026 08:31 AM FibroBiologics begins patient enrollment for diabetic foot ulcer trial
View All Articles

Entities mentioned with FBLG

View All Entities